Long-term effectiveness and safety of ustekinumab (UST) in patients with active Crohn's disease (CD) in real life: Interim analysis of the SUSTAIN study

MLA

Chaparro, M., et al. Long-Term Effectiveness and Safety of Ustekinumab (UST) in Patients with Active Crohn’s Disease (CD) in Real Life: Interim Analysis of the SUSTAIN Study. Jan. 2020. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.RECOLECTA.....fce74bbaa674e2dfd111e4fc0733aa5b&authtype=sso&custid=ns315887.

APA

Chaparro, M., Sulleiro, S., Baston-Rey, I., Rodriguez, C., Garcia-Tercero, I., Ramirez, P., Garcia-Lopez, S., Rojas-Feria, M., Gutierrez, A., Malaves, J., Garcia-Sepulcre, M., Sicilia, B., Bermejo, F., Rodriguez-Moranta, F., Arguelles, F., Marin, I., Leo, E., Arroyo, M., Garcia, M., … SUSTAIN Study Grp. (2020). Long-term effectiveness and safety of ustekinumab (UST) in patients with active Crohn’s disease (CD) in real life: Interim analysis of the SUSTAIN study.

Chicago

Chaparro, M, S Sulleiro, I Baston-Rey, C Rodriguez, I Garcia-Tercero, P Ramirez, S Garcia-Lopez, et al. 2020. “Long-Term Effectiveness and Safety of Ustekinumab (UST) in Patients with Active Crohn’s Disease (CD) in Real Life: Interim Analysis of the SUSTAIN Study,” January. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.RECOLECTA.....fce74bbaa674e2dfd111e4fc0733aa5b&authtype=sso&custid=ns315887.